Hepatitis B HBsAg (Hepatitis B surface antigen) is a marker indicating an active Hepatitis B virus infection. A result of 8.0 indicates a quantifiable level of the antigen in the blood, suggesting that the virus is present and replicating. This could signify either an acute or chronic infection, and further testing may be necessary to determine the stage and management of the disease. It's important to consult a healthcare professional for interpretation and guidance based on this result.
HBsAg reactive means the person has been infected with Hepatitis B virus. HbsAb negative indicates that the person does not have immunity against Hepatitis B. This combination suggests an active Hepatitis B infection without immunity.
HBsAg stands for hepatitis B surface antigen. This antigen is a protein on the surface of the hepatitis B virus and is the marker used to diagnose acute or chronic hepatitis B infection. Detection of HBsAg in the blood indicates an active hepatitis B infection.
A negative Hepatitis B surface antigen (HBsAg) result indicates that the individual is not currently infected with the Hepatitis B virus. This means there is no active viral replication in the body. However, it does not provide information about past infections or immunity, which would require additional tests, such as anti-HBs or anti-HBc, to determine.
A positive HBsAg (Hepatitis B surface antigen) test indicates an active Hepatitis B virus infection. This means that the virus is present in the bloodstream, and the individual is potentially infectious to others. It can be either an acute or chronic infection, and further testing is usually required to determine the stage and appropriate management of the infection. It is important for individuals with a positive HBsAg to consult a healthcare provider for evaluation and potential treatment.
A reactive HBsAg test result indicates the presence of hepatitis B surface antigen in the blood, suggesting a current hepatitis B infection. Further testing may be needed to determine the stage of infection and whether treatment is necessary. Close monitoring and follow-up with a healthcare provider are recommended for proper management.
The HBsAg (Hepatitis B surface antigen) test is used to determine if someone is currently infected with the Hepatitis B virus. A normal or negative result for HBsAg indicates that the individual does not have an active Hepatitis B infection. Typically, a negative result is reported as less than 0.05 IU/mL, while a positive result indicates the presence of the virus. Values above this threshold indicate an active infection that may require further evaluation and monitoring.
HBsAg non-reactive does NOT mean immune to hepatitis B. To understand this we have to discuss what exactly HBsAg is. The hepatitis B virus has several components. It is an encapsulated virus, meaning that its central DNA core is protected by an outer shell. This shell is sometimes called the "surface". On this surface are some antigens, which are simply proteins that induce an immune response in the body. We abbreviate these antigens as HBsAg, which is shorthand for "hepatitis B surface antigen". If a blood test reveals that there are no detectable hepatitis B surface antigens, this simply means that the individual has no evidence of being currently infected with hepatitis B. Otherwise, there would be some hepatitis B surface antigens (with hepatitis B DNA inside them) floating around in the bloodstream. To determine if a person is immune to hepatitis B, we must draw a different test. This test checks for the presence of antibodies to the hepatitis B surface antigens. Sometimes this is abbreviated as HBAb, or as Hepatitis B IgG. If the patient has antibodies to Hepatitis B surface antigens, and has no detectable HBsAg in their bloodstream, then it is likely that they are immune. But be careful! Simply having Hepatitis B surface antibodies does not indicate immunity! It may mean that the person is actually infected with Hep B. This is why both tests are necessary to document immunity.
HbsAg device method is a point-of-care diagnostic test used to detect the presence of the hepatitis B surface antigen (HBsAg) in a person's blood. It typically involves a small device or test kit that provides quick and convenient results, making it suitable for screening individuals for hepatitis B infection in various settings such as clinics, hospitals, or outreach programs.
HBsAg stands for hepatitis B surface antigen, a marker for hepatitis B virus infection. A reactive result indicates presence of the antigen in the blood. The 5898 value is the concentration of the antigen detected, measured in reactive units. COI stands for cutoff index, indicating the level of antibody concentration above which a test is considered positive. This result suggests an active hepatitis B infection.
A result of 4.965 in HBsAg (Hepatitis B surface antigen) testing indicates that the individual is positive for the hepatitis B virus. This suggests an active infection, either acute or chronic, depending on the context and other lab results. It's important for the individual to consult a healthcare provider for further evaluation, management, and possible treatment options.
Identification by symptoms,enlargement of liver,yellow eyes, vomiting ,dyspepsia, etc diagnostic test ,(hb antigen serfice test) HBsAg test,securing test. vaccination ,we have vaccine for hepatitis b,it safe us against hepatitis b.
Yes, it is possible for the hepatitis B surface antigen (HBsAg) to become negative in individuals who were previously positive. This can occur either spontaneously or as a result of effective antiviral treatment. However, even if HBsAg becomes negative, individuals should still be monitored regularly for signs of reactivation.